Gilead Sciences | GILD

Stock Price
77.89
Daily Change
2.20%
Yearly
22.76%
Q2 Forecast
75.63
Rating
Sell

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
AbbVie 136.87 3.43 2.57% -7.00%
Acorda Therapeutics 0.50 -0.05 -9.35% 67.33%
Agios Pharmaceuticals 26.05 0.34 1.32% 32.37%
ALKERMES 29.51 0.23 0.79% 0.68%
Alnylam Pharmaceuticals 193.67 5.00 2.65% 47.26%
Amgen 218.07 3.80 1.77% -12.23%
Biogen 300.20 -2.21 -0.73% 49.64%
Bluebird Bio 3.63 0.09 2.54% 14.87%
BioMarin Pharmaceutical 93.36 5.10 5.78% 20.48%
Bristol-Myers Squibb 65.66 0.98 1.52% -12.65%
Coherus Biosciences 4.45 0.40 9.88% -41.22%
Gilead Sciences 77.89 1.68 2.20% 22.76%
GlaxoSmithKline 1,367.60 20.00 1.48% -19.32%
Glaxosmithkline 34.11 0.31 0.92% -20.15%
Intercept Pharmaceuticals 11.12 0.39 3.63% -32.11%
Incyte Corp 62.54 1.03 1.67% -15.44%
J&J 156.97 2.43 1.57% -11.02%
Eli Lilly 442.33 5.84 1.34% 46.64%
Merck & Co 112.52 1.59 1.43% 25.15%
Moderna 130.51 1.99 1.55% -4.84%
Neurocrine Biosciences 92.32 1.13 1.24% -3.37%
Novartis 89.37 1.31 1.49% 4.12%
Puma Biotechnology 3.55 0.11 3.20% 51.71%
Pfizer 38.36 0.34 0.89% -27.89%
PTC Therapeutics 44.12 0.62 1.43% 53.89%
Regeneron Pharmaceuticals 739.95 8.78 1.20% 17.39%
Sanofi 94.98 0.77 0.82% -5.08%
Sangamo BioSciences 1.15 0.04 3.60% -69.09%
Sarepta Therapeutics 125.16 0.88 0.71% 71.50%
United Therapeutics 217.22 3.74 1.75% -4.99%
Vertex Pharmaceuticals 333.78 10.16 3.14% 23.88%

Indexes Price Day Year
US500 4282 61.35 1.45% 4.23%
USND 13241 139.78 1.07% 10.22%
USNDX 14547 105.13 0.73% 15.93%

Gilead Sciences

Gilead Sciences traded at $77.89 this Friday June 2nd, increasing $1.68 or 2.20 percent since the previous trading session. Looking back, over the last four weeks, Gilead Sciences gained 1.96 percent. Over the last 12 months, its price rose by 22.76 percent. Looking ahead, we forecast Gilead Sciences to be priced at 75.63 by the end of this quarter and at 69.24 in one year, according to Trading Economics global macro models projections and analysts expectations.

Gilead Sciences, Inc. is a biopharmaceutical company that is focused on advancing medicines to prevent and treat diseases, including human immunodeficiency virus (HIV), viral hepatitis and cancer. The Company's portfolio of products and pipeline of investigational drugs includes treatments for HIV/acquired immune deficiency syndrome (AIDS), COVID-19, liver diseases, hematology/oncology/cell therapy and other. Its products for HIV/AIDS patients include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada and Atripla. It offers Veklury to patients with COVID-19. The Company's products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Viread and Vosevi. Its products under hematology/oncology/cell therapy include Yescarta, Tecartus, Trodelvy and Zydelig. Other products include Letairis, Ranexa and AmBisome. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. The Company operates in more than 335 countries worldwide.